Samil Pharmaceutical signs MOU to develop innovative products with Yozma Group Korea
Samil Pharmaceutical(CEO Seung-Bum Huh) signed a memorandum of understanding for strategic partnership and commercialization of innovative new products related to medicine, health functional food and cosmetic with Yozma Group Korea(Branch Manager Won-Jae Lee).
The Yozma Group, a global venture c...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
